Open Access

This article has an erratum: [erratum]

Issue
Med Buccale Chir Buccale
Volume 19, Number 3, juillet 2013
Page(s) 173 - 182
Section Observations cliniques / Case reports
DOI https://doi.org/10.1051/mbcb/2013070
Published online 24 May 2013
  1. Wendling J, Francès C, Thervet E, Agbalika F, Morinet F, Bedrossian J, Morel P, Legendre Ch, Lebbè C. Maladie de Kaposi post-transplantation rénale. Courrier Transplant 2001;1:78-81. [Google Scholar]
  2. Abbaszadeh S, Taheri S. Kaposi's sarcoma after renal transplantation. Saudi J Kidney Dis Transpl 2009;20:775-8. [PubMed] [Google Scholar]
  3. Marcelin A-G. HHV8, maladie de Kaposi et transplantation d'organe : devrions-nous procéder à un dépistage. Virologie 2007;11:279-88. [Google Scholar]
  4. Darling M, Thompson I, Meer M. Oral Kaposi’s sarcoma in a renal transplant patient: case report and literature review. J Can Dent Assoc 2004;70:617-20. [PubMed] [Google Scholar]
  5. HAS. Suivi ambulatoire de l'adulte transplanté rénal au delà de 3 mois après transplantation. http://www.hassante.fr/portail/upload/docs/application/pdf/suivi_du_transplante_renal_-_recommandations.pdf. (page consultée le 12/12/2012). [Google Scholar]
  6. Campistol JM, Schena FP. Kaposi's sarcoma in renal transplant recipients – the impact of proliferation signal inhibitors. Nephrol Dial Transplant 2007;22(suppl 1):17-22. [Google Scholar]
  7. Serraino D, Piselli P, Angeletti C, Minetti E, Pozzetto A, Civati G, Bellelli S, Farchi F, Citterio F, Rezza G, Franceschi S, Busnach G. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer 2005;92:572-5. [PubMed] [Google Scholar]
  8. Harzallah K, Abderrahim E, Charfeddine K, Yeich S, Belhadj R, Skhiri H, Younsi F, Ben Abdallah T,Abdelletif A, Hachicha J, Hmida J, El May M,Khedr A, Manaa J. Cancers after renal transpantation: multicenter experience. Saudi J Kidney Dis Transpl 2008;19:825-30. [PubMed] [Google Scholar]
  9. Muñoz P, Alvarez P, De Ory F, Pozo F, Rivera M, Bouza E. Incidence and clinical characteristics of Kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against HHV-8. Medicine (Baltimore) 2002 81:293-304. [Google Scholar]
  10. El-Agroudy AE, Wafa EW, Gheith OE, Shehab El-Dein AB, Ghoneim MA. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation 2004;77:1381-5. [CrossRef] [PubMed] [Google Scholar]
  11. Lessan-Pezeshki M, Einollahi B, Khatami MR, Mahdavi M. Kidney transplantation and Kaposi’s sarcoma: review of 2050 recipients. Transplant Proc 2001;33:2818. [CrossRef] [PubMed] [Google Scholar]
  12. Cattani P, Capuano M, Graffeo R, Ricci R, Cerimele F, Cerimele D, Nanni G, Fadda G. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol 2001;39:506-8. [CrossRef] [PubMed] [Google Scholar]
  13. Berber I, Altaca G, Aydin C, Dural A, Kara VM, Yigit B, Turkmen A, Titiz MI. Kaposi's sarcoma in renal transplant patients: predisposing factors and prognosis. Transplant Proc 2005;37:967-8. [CrossRef] [PubMed] [Google Scholar]
  14. Zavos G, Bokos J, Papaconstantinou I, Boletis J, Gazouli M, Kakisis J, Zografidis A, Kostakis A. Clinicopathological aspects of 18 Kaposi’s sarcoma among 1055 greek renal transplant recipients. Artif Organs 2004;28:595-9. [CrossRef] [PubMed] [Google Scholar]
  15. Friedersdorff F, Giessing M, Roller C, Baumunk D, Deger S, Budde K, Liefelt L, Hartmann V, Fuller TF. De novo renal transplantation after Kaposi sarcoma: favorable outcome in a patient receiving sirolimus and mycophenolate-based immunosuppression. Case Rep Dermatol 2010;2:32-5. [CrossRef] [PubMed] [Google Scholar]
  16. Johari Y, Nicholson ML. Complete resolution of oral Kaposi's sarcoma achieved by changing immunosuppression: a case report. Ann R Coll Surg Eng 2010;92:W45-6. [CrossRef] [Google Scholar]
  17. Stallone G, Schena A, Infante B, Di Paolo S,Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 2005;352:1317-23. [CrossRef] [PubMed] [Google Scholar]
  18. Hannachi N, Ben Fredj N,Samoud S, Ferjani A, Khlif A, Boughammoura L, Soussi S, Aouni M, Skouri H, Boukadida J. Seroprevalence and risk factors of human herpes virus 8 infection in central-east Tunisia. Pathol Biol (Paris) 2012;60:282-6. [CrossRef] [PubMed] [Google Scholar]
  19. Margolius L, Stein M, Spencer D, Bezwoda WR. Kaposi’s sarcoma in renal transplant recipients: experience at Johannesburg Hospital, 1966-1989. S Afr Med J 1994;84:16-7. [Google Scholar]
  20. Lausten L, Ferguson B, Barker B, Cobb C. Oral Kaposi sarcoma associated with severe alveolar bone loss: case report and review of the literature. J Periodontol 2003;74:1668-75. [CrossRef] [PubMed] [Google Scholar]
  21. Zaraa I, Labbène I, El Guellali I,Ben Alaya N,Mokni M, Ben Osman. La maladie de Kaposi : caractéristiques épidémio-cliniques, anatomopathologiques et thérapeutiques à propos de 75 cas. Tunisie Méd 2012;90:116-21. [Google Scholar]
  22. Qunibi W, Akhtar M, Ginn E, Smith P. Kaposi’s sarcoma in cyclosporine-induced gingival hyperplasia. Am J Kidney Dis 1988;11:349-52. [PubMed] [Google Scholar]
  23. Bowie SJ, Bach D. Oral Kaposi's sarcoma in a non-AIDS patient. Gen Dent 1999;47:413-5. [PubMed] [Google Scholar]
  24. Akasbi Y. Le sarcome de Kaposi de la verge (à propos d'un cas et une revue de la littérature). http://scolaritefmp-usmbaacma/cdim/mediatheque/e_theses/66-09pdf. [Google Scholar]
  25. Chor P, Santa Cruz D. Kaposi’s sarcoma. J Cut Pathol 1992;19:6-20. [CrossRef] [Google Scholar]
  26. Santucci M, Pimpinelli N, Moretti S, Giannotti B. Classic and immunodeficiency-associated Kaposi’s sarcoma. Clinical, histological, and immunologic correlations. Arch Pathol Lab Med 1988;112:1214-20. [PubMed] [Google Scholar]
  27. Fiorelli V, Gendelman R, Sirianni MC, Chang HK, Colombini S, Markham PD, Monini P, Sonnabend J, Pintus A, Gallo RC, Ensoli B. Gamma-interferon produced by CD8+ T cells infiltrating Kaposi’s sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human human herpesvirus-8 infection? Blood 1998;91:956-67. [PubMed] [Google Scholar]
  28. Roth WK, Brandstetter H, Stürzl M. Cellular and molecular features of HIV associated Kaposi’s sarcoma. AIDS 1992;6:895-913. [CrossRef] [PubMed] [Google Scholar]
  29. Regezi J, MacPhail L, Daniels TE, DeSouza YG, Greenspan JS, Greenspan D. Human immunodeficiency virus-associated oral Kaposi’s sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. Am J Pathol 1993;143:240-9. [Google Scholar]
  30. Zhang YM, Bachmann S, Hemmer C, van Lunzen J, von Stemm A, Kern P, Dietrich M, Ziegler R, Waldherr R, Nawroth PP. Vascular origin of Kaposi’s sarcoma. Expression of leukocyte adhesion molecule-1, Thrombomodulin, and tissue factor. Am J Pathol 1994;144:51-9. [PubMed] [Google Scholar]
  31. Jussila L, Valtola R, Partanen TA, Salven P, Heikkilä P, Matikainen MT, Renkonen R, Kaipainen A, Demar M, Tschachler E, Alitalo R, Alitalo K. Lymphatic endothelium and Kaposi’s sarcoma spindle cells detected by antibodies against the VEGF receptor 3. Cancer Res 1998;58:1599-604. [PubMed] [Google Scholar]
  32. Weninger W, Partanen TA, Breiteneder-Geleff S, Mayer C, Kowalski H, Mildner M, Pammer J, Stürzl M, Kerjaschki D, Alitalo K, Tschachler E. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi’s sarcoma tumor cells. Lab Invest 1999;79:243-51. [PubMed] [Google Scholar]
  33. Skobe M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K, Detmar M. Vascular endothelial growth factor-C (VEGF-C) and its receptor KDR and flt-4 are expressed in AIDS-associated Kaposi’s sarcoma. J Invest Dermatol 1999;113:1047-53. [CrossRef] [PubMed] [Google Scholar]
  34. Marcén R, Galeano C, Fernández-Rodriguez A, Jiménez-Alvaro S, Teruel JL, Rivera M, Burgos FJ, Quereda C. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation. Transplant Proc 2010;42:3055-7. [CrossRef] [PubMed] [Google Scholar]
  35. Yilmaz R, Akoglu H, Kirkpantur A, Kilickap S, Arici M, Altun B, Aki T, Erdem Y, Yasavul U, Turgan C. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient. Ren Fail 2007;29:103-5. [CrossRef] [PubMed] [Google Scholar]
  36. Alamartine E, Berthoux F. Complications carcinologiques après transplantation rénale. Presse Méd 1991;20:891-5. [Google Scholar]
  37. Ramírez-Amador V, Esquivel-Pedraza L, Lozada-Nur F, De la Rosa-García E, Volkow-Fernández P, Súchil-Bernal L, Mohar A. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial. Oral Oncol 2002;38:460-7. [CrossRef] [PubMed] [Google Scholar]
  38. Magnone M, Holley J, Shapiro R, Scantlebury V, McCauley J, Jordan M, Vivas C, Starzl T, Johnson J. Interferon-alpha-induced acute allograft rejection. Transplantation 1995;59:1068-70. [CrossRef] [PubMed] [Google Scholar]
  39. Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1979;27:8-11. [CrossRef] [PubMed] [Google Scholar]
  40. Moosa MR. Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. QJM 2005;98:205-14. [CrossRef] [PubMed] [Google Scholar]
  41. Doutrelepont JM, De Pauw L,Gruber SA, Dunn DL, Qunibi W, Kinnaert P, Vereerstraeten P, Penn I, Abramowicz D. Renal transplantation exposes patients with previous Kaposi’sarcoma to a high risk of recurrence. Transplantation 1996;62:463-6. [CrossRef] [PubMed] [Google Scholar]
  42. Euvrard S, Kanitakis J, Bosshard S, Lebbe C, Garnier JL, Touraine JL, Claudy A. No recurrence of posttransplantation Kaposi’s sarcoma three years after renal retransplantation. Transplantation 2002;73:297-9. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.